RIPK1 and systemic inflammatory response syndrome: Recent evidence illustrates that TNF-induced SIRS is a consequence of both caspase-8-dependent apoptosis and MLKL-dependent necroptosis.43 Sorafenib inhibits both RIPK1-dependent apoptosis and necroptosis, which may explain its protective effect during TNF-induced SIRS model.